Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Spondyloarthritis
•
Infectious Disease
•
Pulmonology
•
Critical Care
•
Pulmonary Infections
How would you treat a patient with psoriatic arthritis who developed disseminated histoplasmosis while on adalimumab and previously failed all non-biologic DMARDs?
Would you feel comfortable using a non-TNF biologic DMARD?
Related Questions
What is the recommended fungal workup in an immunocompromised patient after 5 days of persistent fever?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
How would you manage a patient with necrotizing pneumonia due to a susceptible Pseudomonas aeruginosa strain who continues to have significant purulent secretions and worsening imaging while receiving cefepime?
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
Do you use MRSA nares PCR to influence antibiotic selection for non-respiratory infections?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
How do you consider sending fungal studies in a patient with pneumonia?
How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?
Do you recommend treating Candida albicans on urine culture from an indwelling catheter in a patient with septic shock?
What are your vaccine recommendations while patients are on biologics?